Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionFederated Hermes, Inc.
Latest Disclosed Ownership92,812 shares
Latest Disclosed Value $ 2,757,445
Federated Hermes, Inc. reports 35.89% increase in ownership of TVTX / Travere Therapeutics, Inc.

On May 11, 2026 - Federated Hermes, Inc. filed a 13F-HR form disclosing ownership of 92,812 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $2,757,445 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 68,299 shares of Travere Therapeutics, Inc.. This represents a change in shares of 35.89% during the quarter. The current value of the position is $4,195,102 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 92,812 24,513 35.89 2,757 5.67 0.0045
2026-02-12 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 68,299 51,588 308.71 2,610 553.88 0.0044
2025-11-03 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 16,711 -510,827 -96.83 399 -94.89 0.0007
2025-08-13 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 527,538 -145,110 -21.57 7,808 -35.23 0.0147
2025-05-08 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 672,648 4,333 0.65 12,054 3.53 0.0260
2025-02-13 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 668,315 44,500 7.13 11,642 33.40 0.0255
2024-11-13 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 623,815 582,098 1,395.35 8,727 2,451.75 0.0192
2024-08-08 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 41,717 41,717 343 0.0008
2024-01-31 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 0 -97,491 -100.00 0 -100.00
2023-11-13 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 97,491 97,491 872 0.0023
2023-05-08 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 0 -1 -100.00 0 0.0000
2023-02-13 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 1 -1,198 -99.92 0 -100.00 0.0000
2022-11-14 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 1,199 419 53.72 30 50.00 0.0001
2022-09-16 2022-06-30 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 780 -86,154 -99.10 20 -99.11 0.0001
2022-08-15 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 780 -86,154 20 0.0001
2022-05-13 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 86,934 35,822 70.09 2,241 41.21 0.0051
2022-02-14 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 51,112 47,971 1,527.25 1,587 1,988.16 0.0030
2021-11-15 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 3,141 -63,257 -95.27 76 -92.16 0.0001
2021-08-16 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 66,398 -248,419 -78.91 969 -87.67 0.0018
2021-05-13 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 314,817 49,583 18.69 7,861 8.74 0.0152
2021-02-12 2020-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 265,234 196,422 285.45 7,229 469.21 0.0148
2020-11-12 2020-09-30 13F RETROPHIN COM 761299106 68,812 67,392 4,745.92 1,270 4,279.31 0.0030
2020-08-13 2020-06-30 13F RETROPHIN COM 761299106 1,420 -88 -5.84 29 31.82 0.0001
2020-05-13 2020-03-31 13F RETROPHIN COM 761299106 1,508 1,508 22 0.0001
2019-05-10 2019-03-31 13F RETROPHIN COM 761299106 0 -98,485 -100.00 0 -100.00
2019-02-13 2018-12-31 13F RETROPHIN COM 761299106 98,485 4,990 5.34 2,229 -17.01 0.0061
2018-11-13 2018-09-30 13F RETROPHIN COM 761299106 93,495 3,855 4.30 2,686 9.90 0.0063
2018-08-10 2018-06-30 13F RETROPHIN COM 761299106 89,640 89,640 2,444 0.0072
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.